Dolph Lundgren has spent a career selling invincibility on screen, so a memoir about the stretch he spent planning his own death lands as something other than a star confessional. Read past the packaging — the tearful-comeback headlines, the near-crisis-to-renewed-hope framing — and the book documents something the tribute cycle keeps skipping: one of the most recognizable action stars alive was ready to end his life, and the reason he is here to promote it is that the diagnosis driving that decision was wrong.

That is the story worth telling, and it is not the inspirational one. The comeback narrative treats “terminal” as a fact he defied through grit. What actually happened is quieter and far more unsettling: he was being treated for the wrong cancer, and a single second opinion is the reason a plan to die became a book tour.

In the memoir, Lundgren is unsparing about how far he took it. “When I was deep into the cancer treatments and thinking about the possibility of killing myself, my brother, Johan, was going to help me,” he writes, describing a fear of reaching a point where he would be “not capable of completing the suicide on my own.” He looked to Switzerland, where, as he puts it, some European countries “permit legal suicide for people who are terminally ill.” His agent framed the impulse in the actor’s own mythology — he wanted to go out like a Viking rather than let anyone watch him fade. This was not a passing dark thought. It was logistics.

The logistics rested on a mistake. Diagnosed with kidney cancer in 2015 and treated for it for the better part of two years, Lundgren kept deteriorating; the medications simply were not working. It was Dr. Alexandra Drakaki, an oncologist at UCLA Health, who found why. His “kidney cancer” cells carried a mutation more common in lung cancer, and the drugs he had been given were never aimed at it. A mutation-specific targeted therapy changed his trajectory within months. He announced he was cancer-free in 2024; the memoir, Fights Worth Fighting: Finding Strength in Struggle, arrived this week.

This is where the feel-good version does the reader a disservice. Lundgren’s case is not a fluke of celebrity access; it is a vivid version of a well-documented problem. Terminal timelines are among the least reliable figures in medicine — as The Conversation noted in its analysis of his case, clinicians tend to over-predict death, and in one body of research 54 percent of patients told they would die within a given window outlived it. “Terminal” is a probability, not a verdict, and it moves when someone re-reads the evidence. That is the uncomfortable core of the medical-aid-in-dying debate his book walks straight into: the choice is irreversible, and the diagnosis that would justify it is not always right.

None of that makes the case against a person’s right to choose an ending. Lundgren’s wish for control over his own was real, and he states it without apology. But his memoir is being marketed as a story about courage, when the most consequential act in it belongs to a doctor who ordered another test. The line worth carrying out of it is not that he was strong enough to survive. It is that the certainty he nearly staked his life on did not exist — and that the second opinion, not the fighting spirit, is the part that saved him.

Tags: cancer, Dolph Lundgren, medical aid in dying, memoirs, misdiagnosis